Desk›Chemicals› Neogen Chemicals Ltd
Neogen Chemicals Ltd
BSE 542665 · NSE NEOGEN · ISIN INE136S01016 · Group B · Active
Commodities › Chemicals › Chemicals & Petrochemicals › Specialty Chemicals
₹2,209.85
-0.99%
BSE close, 28 August 2026
₹6,050.94 cr
2.7 cr shares · Small cap
₹2,765.97 cr
as published
115.9× · 7.71×
EPS ₹19.06 · BV ₹286.62
855.49 / 46.96
₹ cr, as filed
38
9 selected · 24%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -11.0% |
|---|---|
| Against 52-week low | +126.0% |
| Day change | -0.99% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹19.06 |
|---|---|
| Price / earnings | 115.94× |
| Price / book | 7.71× |
| Book value — derived, price ÷ P/B | ₹286.62 |
| Return on equity | 6.64% |
| Operating margin | 22.22% |
| Net margin | 7.71% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 6.65%
- ROE as published
- 6.64%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 252.28 | 19.44 | 7.15 | 22.22% | 7.71% |
| Mar-26 · Q | 248.63 | 14.66 | 5.56 | 19.81% | 5.90% |
| FY25-26 | 855.49 | 46.96 | 17.81 | 19.53% | 5.49% |
Quarter on quarter
- Revenue, quarter on quarter
- +1.5%
- Net profit, quarter on quarter
- +32.6%
- Operating margin, quarter on quarter
- +241 bps
Disclosure profile 38 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Fundraising | 5 |
| Board Outcome | 1 |
| Change in Management | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 9 |
| Procedural | |
| General | 6 |
| Analyst / Investor Meet | 4 |
| Other Update | 3 |
| AGM / EGM | 2 |
| Book Closure | 2 |
| Monitoring Agency | 2 |
| Newspaper Publication | 2 |
| SAST | 2 |
| Allotment | 1 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 29 |
| Total | 38 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
38 filings · 9 selected · busiest 2026-07-24
Filing rhythm · the twelve most recent
2026-08-312026-09-25
SelectedProcedural
Filings
38 in the window · 6 earlier on record
-
25 September 2026 ·
Closure of Trading Window
Intimation of closure of trading window
Insider Trading / SAST / Closure of Trading Window View filing →
-
23 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Analyst/Investor meet to be held on September 28, 2026.
Company Update / Analyst / Investor Meet View filing →
-
21 September 2026 ·
Press Release / Media Release
Press Release titled " Neogen Chemicals raises approx INR 600 crore via its first ever QIP; Issue oversubscribed by 6.5x
Company Update / Press Release / Media Release View filing →
-
17 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Analyst/Investor meeting to be held on September 22, 2026.
Company Update / Analyst / Investor Meet View filing →
-
17 September 2026 ·
Outcome Of The Meeting Of The Fund-Raising Committee Held On September 16, 2026
Outcome of Fund raising Committee meeting approving allotment of equity shares on QIP basis.
Company Update / General View filing →
-
17 September 2026 ·
Allotment
Outcome of fund raising committee approving allotment of equity shares on QIP basis.
Company Update / Allotment of Equity Shares View filing →
-
17 September 2026 ·
Qualified Institutional Placement
Outcome of Fund raising committee approving allotment of equity shares on QIP basis
Company Update / Qualified Institutional Placement View filing →
-
16 September 2026 ·
Outcome Of Fund Raising Committee
Outcome of Fund raising committee held today approving closure of issue, issue price, placement document, and confirmation of allocation note
Company Update / General View filing →
-
16 September 2026 ·
Qualified Institutional Placement
Outcome of Fund Raising Committee held today approving closure of issue, issue price, placement document and confirmation of allocation note.
Company Update / Qualified Institutional Placement View filing →
-
10 September 2026 ·
Outcome Of Fund Raising Committee Meeting Held Today
Approval of Issue opening date and Floor price and PPD.
Company Update / General View filing →
-
10 September 2026 ·
Qualified Institutional Placement
Outcome of Fund raising committee meeting held today for opening of QIP issue.
Company Update / Qualified Institutional Placement View filing →
-
31 August 2026 ·
Disclosure Pursuant To Regulation 30 (9) Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').
Approval for execution of Business Transfer Agreement between NIL and NML for sale/ transfer of undertaking/ assets as mentioned in detail in BTA by NIL to NML.
Company Update / General View filing →
-
21 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 37th AGM.
AGM/EGM / AGM View filing →
-
20 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
20 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
30 July 2026 ·
Newspaper Publication
Notice of 37th AGM to be held on 21-08-2026 in newspaper publication.
Company Update / Newspaper Publication View filing →
-
30 July 2026 ·
Intimation Of Book Closure Period And Record Date For 37Th AGM To Be Held On 21-08-2026.
Intimation of book closure period and record date for 37th AGM to be held on 21-08-2026.
Corp. Action / Book Closure View filing →
-
30 July 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
BRSR and BRSR Assurance Report FY 2025-26.
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
30 July 2026 ·
Notice Of 37Th AGM And Integrated Annual Report For FY 2025-26
Notice of 37th AGM and Integrated Annual Report for FY 2025-26.
AGM/EGM / AGM View filing →
-
30 July 2026 ·
Reg. 34 (1) Annual Report.
Integrated Report for F.Y. 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
27 July 2026 ·
Outcome Of Analysts/ Investors Conference Call - Call Recording.
Outcome of Analysts/ Investors Conference Call - Call Recording.
Company Update / General View filing →
-
27 July 2026 ·
Analyst / Investor Meet - Outcome
Earnings conference call recording.
Company Update / Analyst / Investor Meet View filing →
-
24 July 2026 ·
Intimation Of Book Closure Period
Intimation of Book closure period.
Corp. Action / Book Closure View filing →
-
24 July 2026 ·
Monitoring Agency Report
Revised Statement of Deviation/ Variation .
Company Update / Monitoring Agency Report View filing →
-
24 July 2026 ·
Revised Statement Of Deviation/Variation
Revised Statement of Deviation/ Variation
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
24 July 2026 ·
Compliances-Reg. 54 - Asset Cover details
Asset cover certificate for the quarter ended June 30, 2026.
Others / Reg. 54 - Asset Cover details View filing →
-
24 July 2026 ·
Monitoring Agency Report
Monitoring Agency report and Statement of Deviation/ variation.
Company Update / Monitoring Agency Report View filing →
-
24 July 2026 ·
Statement Of Deviation/ Variation And Monitoring Agency Report
Statement of Deviation & Variation and Monitoring Agency report
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
24 July 2026 ·
Change in Management
Appointment of Internal Auditors for FY 2026-27
Company Update / Change in Management View filing →
-
24 July 2026 ·
Qualified Institutional Placement
Granting of Inprinciple approval for raising of funds upto 600 crore.
Company Update / Qualified Institutional Placement View filing →
-
24 July 2026 ·
Outcome Of Board Meeting
Approval of financials for the quarter ended 30-06-2026, statement of deviation / variation, approved integrated annual report for fy 2025-26, fixing cut off date and book closure period, ....
Company Update / General View filing →
-
24 July 2026 ·
Outcome Of Board Meeting
Approval of Record date and Book closure period.
Corp. Action / Record Date View filing →
-
24 July 2026 ·
Raising of Funds
Inprinciple approval for raising of funds upto 600 crore.
Company Update / Raising of Funds View filing →
-
24 July 2026 ·
Financial Results For The Quarter Ended June 30,2026.
Unaudited Financial Results for the quarter ended June 30, 2026
Result / Financial Results View filing →
-
24 July 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On 24-07-2026
Approval of financials for the quarter ended June 30,2026, Statement of Deviation/ variation, Approval of Integrated Report for FY 2025-26, fixing of cut off date and book closure date ....
Board Meeting / Outcome of Board Meeting View filing →
-
23 July 2026 ·
Newspaper Publication
Newspaper Publication with respect to transfer of Equity shares of the Company to IEPF.
Company Update / Newspaper Publication View filing →
-
20 July 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Earnings Conference Call scheduled to be held on Monday, July 27, 2026, at 4.00 p.m.
Company Update / Analyst / Investor Meet View filing →
-
20 July 2026 ·
542665 - Board Meeting Intimation for A) Approval Of Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended On June 30, 2026. B) Approval For Issuance Of Securities Through Permissible Modes Of Fund-Raising
Neogen Chemicals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve a) approval of un-audited ....
Board Meeting / Board Meeting View filing →
RSS feed for Neogen Chemicals Ltd · the 50 most recent filings